Paul Flechsig

5.2k total citations · 3 hit papers
45 papers, 3.4k citations indexed

About

Paul Flechsig is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Paul Flechsig has authored 45 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Radiology, Nuclear Medicine and Imaging, 23 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in Paul Flechsig's work include Radiopharmaceutical Chemistry and Applications (12 papers), Peptidase Inhibition and Analysis (11 papers) and Medical Imaging Techniques and Applications (10 papers). Paul Flechsig is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (12 papers), Peptidase Inhibition and Analysis (11 papers) and Medical Imaging Techniques and Applications (10 papers). Paul Flechsig collaborates with scholars based in Germany, United States and Austria. Paul Flechsig's co-authors include Uwe Haberkorn, Frederik L. Giesel, Clemens Kratochwil, Jürgen Debus, Walter Mier, Annette Altmann, Thomas Lindner, Manuel Röhrich, Hendrik Rathke and Sebastian Adeberg and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

In The Last Decade

Paul Flechsig

44 papers receiving 3.3k citations

Hit Papers

68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of ... 2018 2026 2020 2023 2019 2018 2018 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Flechsig Germany 25 2.1k 1.4k 1.1k 1.1k 984 45 3.4k
Hendrik Rathke Germany 26 2.0k 0.9× 1.7k 1.2× 880 0.8× 1.1k 1.1× 817 0.8× 52 3.1k
Haojun Chen China 32 2.7k 1.3× 1.1k 0.8× 1.4k 1.3× 358 0.3× 1.4k 1.4× 135 3.7k
Long Sun China 28 2.2k 1.0× 799 0.6× 1.1k 1.1× 353 0.3× 1.2k 1.2× 86 2.7k
Manuel Röhrich Germany 19 2.1k 1.0× 671 0.5× 1.1k 1.0× 293 0.3× 1.0k 1.1× 51 2.5k
Anastasia Loktev Germany 12 2.3k 1.1× 736 0.5× 1.1k 1.1× 167 0.2× 1.2k 1.2× 13 2.7k
Yizhen Pang China 23 2.1k 1.0× 619 0.5× 1.2k 1.1× 163 0.2× 1.1k 1.1× 69 2.4k
Matthew G. Fury United States 38 2.1k 1.0× 802 0.6× 347 0.3× 1.3k 1.2× 1.0k 1.1× 165 4.4k
Chang‐Ok Suh South Korea 38 1.6k 0.8× 582 0.4× 930 0.9× 1.3k 1.2× 1.2k 1.2× 250 4.8k
Stefan A. Koerber Germany 24 1.1k 0.5× 550 0.4× 617 0.6× 589 0.6× 786 0.8× 70 1.9k

Countries citing papers authored by Paul Flechsig

Since Specialization
Citations

This map shows the geographic impact of Paul Flechsig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Flechsig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Flechsig more than expected).

Fields of papers citing papers by Paul Flechsig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Flechsig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Flechsig. The network helps show where Paul Flechsig may publish in the future.

Co-authorship network of co-authors of Paul Flechsig

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Flechsig. A scholar is included among the top collaborators of Paul Flechsig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Flechsig. Paul Flechsig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Röhrich, Manuel, Dominik Leitz, Annika K. Wefers, et al.. (2021). Fibroblast Activation Protein–Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study. Journal of Nuclear Medicine. 63(1). 127–133. 105 indexed citations
2.
Giesel, Frederik L., Sebastian Adeberg, Mustafa Syed, et al.. (2020). FAPI-74 PET/CT Using Either18F-AlF or Cold-Kit68Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients. Journal of Nuclear Medicine. 62(2). 201–207. 192 indexed citations
3.
Röhrich, Manuel, Ralf Floca, Sebastian Adeberg, et al.. (2020). FAP-specific PET signaling shows a moderately positive correlation with relative CBV and no correlation with ADC in 13 IDH wildtype glioblastomas. European Journal of Radiology. 127. 109021–109021. 30 indexed citations
4.
Syed, Mustafa, Paul Flechsig, Jakob Liermann, et al.. (2020). Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers. European Journal of Nuclear Medicine and Molecular Imaging. 47(12). 2836–2845. 122 indexed citations
5.
Röhrich, Manuel, Anastasia Loktev, Annika K. Wefers, et al.. (2019). IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein–specific PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 46(12). 2569–2580. 110 indexed citations
6.
Baumann, In go, Peter K. Plinkert, Johannes Krisam, et al.. (2019). Validating the Xerostomia Inventory in a radiation‐induced xerostomia population in German language. Oral Diseases. 25(7). 1744–1750. 15 indexed citations
7.
Rathke, Hendrik, Tim Holland‐Letz, Walter Mier, et al.. (2019). Response Prediction of 177Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase. Journal of Nuclear Medicine. 61(5). 689–695. 48 indexed citations
8.
Roesch, Saskia, Thomas Lindner, Max Sauter, et al.. (2018). Comparison of the RGD Motif–Containing αvβ6Integrin–Binding Peptides SFLAP3 and SFITGv6 for Diagnostic Application in HNSCC. Journal of Nuclear Medicine. 59(11). 1679–1685. 42 indexed citations
9.
Vollherbst, Dominik F., Thuy Do, Kerstin Hölzer, et al.. (2018). Computed tomography and histopathological findings after embolization with inherently radiopaque 40μm-microspheres, standard 40μm-microspheres and iodized oil in a porcine liver model. PLoS ONE. 13(7). e0198911–e0198911. 3 indexed citations
10.
Flechsig, Paul, Clemens Kratochwil, Ole Martin, et al.. (2018). Impact of Computer-Aided CT and PET Analysis on Non-invasive T Staging in Patients with Lung Cancer and Atelectasis. Molecular Imaging and Biology. 20(6). 1044–1052. 4 indexed citations
11.
Giesel, Frederik L., Clemens Kratochwil, Thomas Lindner, et al.. (2018). 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers. Journal of Nuclear Medicine. 60(3). 386–392. 488 indexed citations breakdown →
12.
Rathke, Hendrik, Frederik L. Giesel, Paul Flechsig, et al.. (2017). Repeated 177Lu-Labeled PSMA-617 Radioligand Therapy Using Treatment Activities of Up to 9.3 GBq. Journal of Nuclear Medicine. 59(3). 459–465. 64 indexed citations
13.
Flechsig, Paul, Clemens Kratochwil, Laila König, et al.. (2017). Role of CT Density in PET/CT-Based Assessment of Lymphoma. Molecular Imaging and Biology. 20(4). 641–649. 6 indexed citations
14.
Freitag, Martin T., Claudia Kesch, Jens Cardinale, et al.. (2017). Simultaneous whole-body 18F–PSMA-1007-PET/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological staging of patients with prostate cancer: a pilot study. European Journal of Nuclear Medicine and Molecular Imaging. 45(3). 340–347. 29 indexed citations
15.
Freitag, Martin T., Jan Philipp Radtke, Ali Afshar‐Oromieh, et al.. (2016). Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI. European Journal of Nuclear Medicine and Molecular Imaging. 44(5). 776–787. 117 indexed citations
16.
Flechsig, Paul, Peter L. Choyke, Clemens Kratochwil, et al.. (2015). Increased x-ray attenuation in malignant vs. benign mediastinal nodes in an orthotopic model of lung cancer. Diagnostic and Interventional Radiology. 22(1). 35–39. 7 indexed citations
17.
Flechsig, Paul, Clemens Kratochwil, Arne Warth, et al.. (2015). A Comparison of microCT and microPET for Evaluating Lymph Node Metastasis in a Rat Model. Molecular Imaging and Biology. 18(2). 243–248. 4 indexed citations
18.
Flechsig, Paul, Monika Dadrich, Sebastian Bickelhaupt, et al.. (2012). LY2109761 Attenuates Radiation-Induced Pulmonary Murine Fibrosis via Reversal of TGF-β and BMP-Associated Proinflammatory and Proangiogenic Signals. Clinical Cancer Research. 18(13). 3616–3627. 127 indexed citations
19.
Flechsig, Paul, Bettina Hartenstein, Monika Dadrich, et al.. (2010). Loss of Matrix Metalloproteinase-13 Attenuates Murine Radiation-Induced Pulmonary Fibrosis. International Journal of Radiation Oncology*Biology*Physics. 77(2). 582–590. 37 indexed citations
20.
Phan, Catherine, Eric A. Macklin, Miriam A. Bredella, et al.. (2010). Trabecular structure analysis using C-arm CT: comparison with MDCT and flat-panel volume CT. Skeletal Radiology. 40(8). 1065–1072. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026